Share Email Print
cover

Proceedings Paper

Photodynamic therapy with 5-aminoolevulinic acid-induced porphyrins and DMSO/EDTA for basal cell carcinoma
Author(s): Trond Warloe; Qian Peng; Helen Heyerdahl; Johan Moan; Harald B. Steen; Karl-Erik Giercksky
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Seven hundred sixty three basal cell carcinomas (BCCs) in 122 patients were treated by photodynamic therapy by 5-aminolevulinic acid (ALA) in cream topically applied, either alone, in combination with dimethyl sulphoxide (DMSO) and ethylenediaminetetraacetic acid disodium salt (EDTA), or with DMSO as a pretreatment. After 3 hours cream exposure 40 - 200 Joules/cm2 of 630 nm laser light was given. Fluorescence imaging of biopsies showed highly improved ALA penetration depth and doubled ALA-induced porphyrin production using DMSO/EDTA. Treatment response was recorded after 3 months. After a single treatment 90% of 393 superficial lesions responded completely, independent of using DMSO/EDTA. In 363 nodulo-ulcerative lesions the complete response rate increased from 67% to above 90% with DMSO/EDTA for lesions less than 2 mm thickness and from 34% to about 50% for lesions thicker than 2 mm. Recurrence rate observed during a follow-up period longer than 12 months was 2 - 5%. PDT of superficial thin BCCs with ALA-induced porphyrins and DMSO/EDTA equals surgery and radiotherapy with respect to cure rate and recurrence. Cosmetic results of ALA-based PDT seemed to be better than those after other therapies. In patients with the nevoid BCC syndrome the complete response rate after PDT was far lower.

Paper Details

Date Published: 1 March 1995
PDF: 10 pages
Proc. SPIE 2371, 5th International Photodynamic Association Biennial Meeting, (1 March 1995); doi: 10.1117/12.203454
Show Author Affiliations
Trond Warloe, Institute for Cancer Research/The Norwegian Radium Hospital (Norway)
Qian Peng, Institute for Cancer Research/The Norwegian Radium Hospital (Norway)
Helen Heyerdahl, Institute for Cancer Research/The Norwegian Radium Hospital (Norway)
Johan Moan, Institute for Cancer Research/The Norwegian Radium Hospital (Norway)
Harald B. Steen, Institute for Cancer Research/The Norwegian Radium Hospital (Norway)
Karl-Erik Giercksky, Institute for Cancer Research/The Norwegian Radium Hospital (Norway)


Published in SPIE Proceedings Vol. 2371:
5th International Photodynamic Association Biennial Meeting
Denis A. Cortese, Editor(s)

© SPIE. Terms of Use
Back to Top